Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists
- PMID: 3919944
Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists
Abstract
Daunorubicin transport was compared in P388 murine leukemia and in P388/Adramycin (ADR), an anthracycline-resistant subline. We can demonstrate an energy-dependent outward transport system in P388/ADR which limits drug accumulation. Although no calcium requirement for the outward transport process could be shown, several calcium antagonists inhibited outward transport of daunorubicin in P388/ADR and modified the drug resistance pattern. But these agents failed to alter calcium fluxes in either cell line, suggesting that their mode of action in these studies was not related to interactions with calcium-dependent processes. Accumulation differences could not account for the level of daunorubicin resistance observed in the P388/ADR cell line, nor could resistance be wholly circumvented by calcium antagonists.
Similar articles
-
Promotion of daunorubicin uptake and toxicity by the calcium antagonist tiapamil and its analogs.Cancer Treat Rep. 1985 Jun;69(6):673-6. Cancer Treat Rep. 1985. PMID: 4016770
-
Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.Cancer Res. 1986 Sep;46(9):4352-6. Cancer Res. 1986. PMID: 3460695
-
Interactions between calcium antagonists, calcium fluxes and anthracycline transport.Cancer Lett. 1984 Nov;25(1):97-101. doi: 10.1016/s0304-3835(84)80031-2. Cancer Lett. 1984. PMID: 6097354
-
Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cells.Cancer Treat Rep. 1983 Oct;67(10):895-9. Cancer Treat Rep. 1983. PMID: 6354437 Review.
-
Circumvention of resistance to anthracyclines by calcium antagonists and other membrane-perturbing agents.Cancer Surv. 1986;5(1):109-27. Cancer Surv. 1986. PMID: 3297311 Review.
Cited by
-
Sensitivity and resistance to chemotherapy in acute leukemia: correlation with in vitro drug uptake and lack of potentiation by verapamil.Med Oncol Tumor Pharmacother. 1987;4(1):17-21. doi: 10.1007/BF02934930. Med Oncol Tumor Pharmacother. 1987. PMID: 3600053
-
Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression.Br J Cancer. 1991 Mar;63(3):351-7. doi: 10.1038/bjc.1991.84. Br J Cancer. 1991. PMID: 1672252 Free PMC article.
-
Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent.Cancer Chemother Pharmacol. 1994;34(3):249-56. doi: 10.1007/BF00685085. Cancer Chemother Pharmacol. 1994. PMID: 8004759
-
Reversal of multidrug resistance by new dihydropyridines with lower calcium antagonistic activity.Cancer Chemother Pharmacol. 1989;24(6):367-70. doi: 10.1007/BF00257444. Cancer Chemother Pharmacol. 1989. PMID: 2791190
-
Resistance of human glioma to adriamycin in vitro: the role of membrane transport and its circumvention with verapamil.Br J Cancer. 1986 Jan;53(1):129-35. doi: 10.1038/bjc.1986.18. Br J Cancer. 1986. PMID: 3947509 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials